Trial Information

Summary: The SETPOINT Study—A Randomized Study of the Effect of Immediate Treatment with Potent Antiretroviral Therapy versus Observation with Treatment as Indicated in Newly Infected HIV-1-infected Subjects: Does Early Therapy Alter the Virologic Setpoint?

HIV Therepeutic Research Study For Newly Infected Subjects

You may qualify if you:

- Tested HIV negative within the past 6 months
- CD4 T-Cell count greater than or equal to 350 within the past month
- Viral load is greater than or equal to 500 within the past month
- No prior antiretroviral therapy

For more information call 617-726-3819.

Contact:

Theresa Flynn, RN, ANP
Massachusetts General Hospital (MGH)
55 Fruit Street
Boston, MA 02114
Telephone: 617-726-3819
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 7, 2008 at 3:16:04 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA